- Events
03/09/2026
EASL 2025 - Supporting Liver Disease Innovation
We are pleased to announce that TransCure bioServices will be attending the EASL Congress 2025, taking place from May 7 to 10 in Amsterdam, Netherlands.
The EASL Congress is one of the world’s leading events dedicated to liver disease research, bringing together clinicians, researchers, and industry experts to share cutting-edge science and therapeutic advances.
At TransCure bioServices, we are proud to advance liver disease research with our cutting-edge humanized liver and double humanized mouse models-featuring both human liver and immune system engraftment. These models enable robust preclinical evaluation of therapies for hepatitis, MASH, fibrosis, gene editing and other complex liver-related conditions.
Whether you’re developing antiviral strategies, exploring immune-mediated inflammation, or targeting metabolic dysfunction, our platforms offer exceptional translational relevance—bringing your therapeutic innovations one step closer to the clinic.
???? Let’s connect in Amsterdam to explore how our preclinical solutions can support your liver disease programs.
